| Submit your comments on this article |
| Economy |
| J&J (JNJ) Beats on Q1 Earnings & Sales, Ups 2018 Sales View April 17, 2018 |
| 2018-04-17 |
| [Zachs] Johnson & Johnson (JNJ - Free Report) , the bellwether of healthcare companies, has a strong presence in the pharmaceutical, medical devices and consumer care markets across the world. This New Jersey-based company is well known for its baby-care products and brands like Tylenol in addition to drugs like Remicade and Concerta. However, like many of its peers, JNJ is facing generic competition and pricing pressure for some of the products in its pharmaceutical segment. In this scenario, investor focus remains on late-stage pipeline candidates and their commercial potential as well as the performance of new products apart from the usual top-and bottom-line numbers. JNJ has a pretty good earnings track record with the company delivering positive earnings surprises in each of the last four quarters, with an average positive surprise of 3.09%. Estimate movement has been stable over the past 7 days. |
| Posted by:Besoeker |
| #1 That's alot of Band-Aids(tm)! |
| Posted by: AlmostAnonymous5839 2018-04-17 10:48 |